Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) active compounds. Its structure supports the creation of bioactive molecules due to the presence of the piperazine ring and the reactive fluoroethyl group. Commonly employed in medicinal chemistry for constructing drug candidates targeting neurological disorders, including antidepressants, antipsychotics, and anxiolytics. Also utilized in the preparation of radiolabeled derivatives for positron emission tomography (PET) imaging studies. Its versatility makes it valuable in both early-stage research and process development within the pharmaceutical industry.